Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Assets (2020 - 2025)

SOPHiA GENETICS's Assets history spans 6 years, with the latest figure at $163.0 million for Q4 2025.

  • On a quarterly basis, Assets rose 4.97% to $163.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $163.0 million, a 4.97% increase, with the full-year FY2025 number at $163.0 million, up 4.97% from a year prior.
  • Assets hit $163.0 million in Q4 2025 for SOPHiA GENETICS, roughly flat from $163.5 million in the prior quarter.
  • Over the last five years, Assets for SOPH hit a ceiling of $334.9 million in Q3 2021 and a floor of $104.0 million in Q2 2021.
  • Historically, Assets has averaged $212.7 million across 5 years, with a median of $205.9 million in 2023.
  • The widest YoY moves for Assets: up 166.45% in 2022, down 25.18% in 2022.
  • Tracing SOPH's Assets over 5 years: stood at $320.2 million in 2021, then fell by 23.84% to $243.8 million in 2022, then dropped by 15.45% to $206.2 million in 2023, then decreased by 24.66% to $155.3 million in 2024, then increased by 4.97% to $163.0 million in 2025.
  • Business Quant data shows Assets for SOPH at $163.0 million in Q4 2025, $163.5 million in Q3 2025, and $177.6 million in Q2 2025.